✦ LIBER ✦

A phase II trial of ifosfamide (I), etoposide (E), carboplatine (C) and cisplatin (CDDP) in small cell lung cancer (SCLC)

✍ Scribed by Mahjoubi, R; Llory, J.F; Brugière, O; Vannetzel, J.M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of ifosfamide (I), etop

✍ Mahjoubi, R; Llory, J; Brugiere, O; Vannetzel, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 131 KB

A phase II trial of carboplatin (C), ifo

✍ Casal, J.; Garcia, J.; Garrido, P.; Movand, A.; Crespo, C.; Diz, P. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Ifosfamide, epirubicin and vincristine a

✍ Rodrígeuz, CA; Martín, G; López, Y; Cruz, JJ 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Phase I trial of topotecan (T) carboplat

✍ Gillenwater, H.H; McCune, J.S; Donahue, A.E; Faucette, S.R; Shifflett, S; Lindle 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Phase I/II trial of etoposide and carbop

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Cisplatin, etoposide and gemcitabine in

✍ De Marinis, F.; Cortesi, E.; Gareri, R.; Ripanti, P.; Grifalchi, F.; Cipri, A.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 98 KB